CA2104501A1 - Di- and triazinediones - Google Patents

Di- and triazinediones

Info

Publication number
CA2104501A1
CA2104501A1 CA002104501A CA2104501A CA2104501A1 CA 2104501 A1 CA2104501 A1 CA 2104501A1 CA 002104501 A CA002104501 A CA 002104501A CA 2104501 A CA2104501 A CA 2104501A CA 2104501 A1 CA2104501 A1 CA 2104501A1
Authority
CA
Canada
Prior art keywords
formula
methyl
compound
cnh2n
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002104501A
Other languages
English (en)
French (fr)
Inventor
Werner Mederski
Dieter Dorsch
Mathias Osswald
Pierre Schelling
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CA2104501A1 publication Critical patent/CA2104501A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/20Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002104501A 1992-08-23 1993-08-20 Di- and triazinediones Abandoned CA2104501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4227773A DE4227773A1 (de) 1992-08-23 1992-08-23 Di- bzw. Triazindione
DEP4227773.6 1992-08-23

Publications (1)

Publication Number Publication Date
CA2104501A1 true CA2104501A1 (en) 1994-02-24

Family

ID=6466102

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002104501A Abandoned CA2104501A1 (en) 1992-08-23 1993-08-20 Di- and triazinediones

Country Status (15)

Country Link
EP (1) EP0589201A1 (enrdf_load_stackoverflow)
JP (1) JPH06184118A (enrdf_load_stackoverflow)
KR (1) KR940003941A (enrdf_load_stackoverflow)
CN (1) CN1086214A (enrdf_load_stackoverflow)
AU (1) AU4469193A (enrdf_load_stackoverflow)
CA (1) CA2104501A1 (enrdf_load_stackoverflow)
CZ (1) CZ166793A3 (enrdf_load_stackoverflow)
DE (1) DE4227773A1 (enrdf_load_stackoverflow)
HU (1) HUT70201A (enrdf_load_stackoverflow)
MX (1) MX9305076A (enrdf_load_stackoverflow)
NO (1) NO932967L (enrdf_load_stackoverflow)
PL (1) PL300165A1 (enrdf_load_stackoverflow)
SK (1) SK88493A3 (enrdf_load_stackoverflow)
TW (1) TW242620B (enrdf_load_stackoverflow)
ZA (1) ZA936135B (enrdf_load_stackoverflow)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
ATE169915T1 (de) * 1990-02-15 1998-09-15 Takeda Chemical Industries Ltd Pyrimidindionderivate, deren herstellung und verwendung

Also Published As

Publication number Publication date
NO932967D0 (no) 1993-08-20
KR940003941A (ko) 1994-03-14
NO932967L (no) 1994-02-24
ZA936135B (en) 1994-03-17
CN1086214A (zh) 1994-05-04
TW242620B (enrdf_load_stackoverflow) 1995-03-11
SK88493A3 (en) 1994-06-08
HU9302380D0 (en) 1993-11-29
HUT70201A (en) 1995-09-28
DE4227773A1 (de) 1994-02-24
CZ166793A3 (en) 1994-03-16
AU4469193A (en) 1994-02-24
JPH06184118A (ja) 1994-07-05
EP0589201A1 (de) 1994-03-30
PL300165A1 (en) 1994-03-07
MX9305076A (es) 1994-04-29

Similar Documents

Publication Publication Date Title
CA2036304C (en) Pyrimidinedione derivatives, their production and use
US5401738A (en) Benzimidazole compounds
ES2226996T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
EP0443568B1 (en) Fused thiophene derivatives, their production and use
EP0691967B1 (en) Nitrogen-containing fused-heterocycle compounds
HU229403B1 (en) Novel sulfamides and their use as endothelin receptor antagonists
US8399668B2 (en) Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides
SK149294A3 (en) Imidazopyridines, method of their production and pharmaceutical agents on their base and method of their production
CA3183465A1 (en) Quinoline derivatives, pharmaceutically acceptable salts, and methods of use thereof
EP0829479B1 (en) Heterocyclic compounds and their use as angiotensin II antagonists
US20120197019A1 (en) Compositions and processes
EP0039190A1 (en) 2-(1-Piperazinyl)-4-pyrimidinamines and related compounds
CA2104501A1 (en) Di- and triazinediones
CA2093290A1 (en) Imidazopyridines
JP3093170B2 (ja) ヒドロキノン誘導体及びその医薬用途
WO2010095462A1 (ja) 新規な3-(5-アルコキシピリミジン-2-イル)ピリミジン-4(3h)-オン構造を有する化合物及びこれを含有する医薬
US20120122906A1 (en) Novel sulfonamide derivative and pharmaceutical product containing same
HUE028252T2 (en) New phenylpyridine derivative and drug containing it
JP3032844B2 (ja) ピリミジンジオン誘導体
JPH07116188B2 (ja) 新規ピリド〔4,3−d〕ピリミジン誘導体、その製造方法並びに該化合物を含有する医薬組成物
AU618183B2 (en) Diazine derivatives, a process for their preparation and medicaments containing these compounds
JP2662765B2 (ja) ピリド〔2,3−d〕ピリミジン誘導体を含有する医薬組成物
US20090074791A1 (en) Phenylisoquinoline and Phenylquinazoline Derivatives
CA2181260A1 (en) Potassium salt of biphenylmethane derivative and medicine containing the same
JP2631888B2 (ja) チエノピリミジン誘導体

Legal Events

Date Code Title Description
FZDE Discontinued